---

Chemel is developing, producing and selling chemical analytical equipment (i.e. SIRE Biosensor) and reagents for industry, process control and patient monitoring. Today, the company products offer laboratory analysis for glucose, lactate, ethanol, methanol, sucrose, oxalate, ascorbic acid, lactose and maltose. European Institute of Science owns 19.3 % of the stock in Chemel. Click here to visit Chemels homepage.


LifeAssays is developing a new Point of Care blood and urine analysis system suitable for mass screening of various common diseases. Presently, a study on over 100 patients using the technology showed excellent results for rapid assessment of C-Reactive protein (CRP) in whole blood. Two other tests for albumine and cystatin C are also beeing developed. European Institute of Science owns 13.4 % of the stock in LifeAssays and has an annual 2 % roylaty agreement. Click here to visit LifeAssays homepage.


Previous portfolio company Implementa Hebe is developing, producing and selling magnetic stirrers with cooling and heating capabilities for laboratory applications. European Institute of Science owns <1 % of the stock in Implementa Hebe and has an annual 5 % roylaty agreement. EURIS made an EXIT during 2006 which resultet in a profit at 1,701 million SEK. Click here to visit Implementa Hebes homepage.


Previous portfolio company Genovis is developing a new technology platform for molecular biology and gene transfer. European Institute of Science owns 0 % of the stock in Genovis. EURIS made an EXIT during 2007 which resultet in a profit at 5,000 million SEK.Click here to visit Genovis homepage.